ASML vs LFUS

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

LFUS presents a stable deterministic health profile with a Piotroski F-Score of 5/9 and exceptionally strong liquidity (Current Ratio 2.69). However, the stock is currently trading at its 52-week high following a massive 153% one-year rally, resulting in a stretched valuation with a PEG ratio of 2.46. While the company maintains a stellar 25-quarter earnings beat track record and healthy revenue growth, the current negative net profit margin and ROE are concerning. With a technical trend score of 10/100 and bearish insider activity, the stock appears to be in a consolidation or peak phase.